Characterisation of the influence of genetic variations on the enzyme activity of a recombinant human glycine N-acyltransferase

Gene

Volumn 515, Issue 2, 2013, Pages 447-453

  Van der Sluis, Rencia ^a   Badenhorst, Christoffel P S ^a   Van der Westhuizen, Francois H ^a   Van Dijk, Alberdina A ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Detoxification; Enzyme activity; Human GLYAT; SNP

Indexed keywords

ACYLTRANSFERASE; ARGININE; HUMAN GLYCINE N ACYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); DETOXIFICATION; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN MOTIF; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; WILD TYPE;

ACYLTRANSFERASES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CATALYTIC DOMAIN; ESCHERICHIA COLI; GENE FREQUENCY; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS;

EID: 84872500403     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.003     Document Type: Article

References (39)

1. Badenhorst C.P.S., Jooste M., van Dijk A.A. Enzymatic characterization and elucidation of the catalytic mechanism of a recombinant bovine glycine N-acyltransferase. Drug Metab. Dispos. 2012, 40:346-352.
2. Bartlett K., Gompertz D. The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias. Biochem. Med. 1974, 10:15-23.
3. Campbell L., Wilson H.K., Samuel A.M., Gompertz D. Interactions of m-xylene and aspirin metabolism in man. Br. J. Ind. Med. 1988, 45:127-132.
4. Dercksen M., et al. Clinical variability of isovaleric acidemia in a genetically homogeneous population. J. Inherit. Metab. Dis. 2012, 2012:17.
5. Duffy L.F., Kerzner B., Seeff L., Barr S.B., Soldin S.J. Preliminary assessment of glycine conjugation of para-aminobenzoic acid as a quantitative test of liver function. Clin. Biochem. 1995, 28:527-530.
6. Dyda F., Klein D.C., Hickman A.B. GCN5-related N-acetyltransferases: a structural overview. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:81-103.
7. Gregersen N., Kolvraa S., Mortensen P.B. Acyl-CoA: glycine N-acyltransferase: in vitro studies on the glycine conjugation of straight- and branched-chained acyl-CoA esters in human liver. Biochem. Med. Metab. Biol. 1986, 35:210-218.
8. Jakoby W., Ziegler D. The enzymes of detoxification. J. Biol. Chem. 1990, 265:20715-20718.
9. Kelley M., Vessey D.A. Isolation and characterization of mitochondrial acyl-CoA: glycine N-acyltransferases from kidney. J. Biochem. Toxicol. 1993, 8:63-69.
10. Kelley M., Vessey D. Characterization of the acyl-CoA: amino acid N-acyltransferases from primate liver mitochondria. J. Biochem. Toxicol. 1994, 9:153-158.
11. Kinzig-Schippers M., et al. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?. Antimicrob. Agents Chemother. 2005, 1733-1738.
12. Kolvraa S., Gregersen N. Acyl-CoA:glycine N-acyltransferase: organelle localization and affinity toward straight- and branched-chained acyl-CoA esters in rat liver. Biochem. Med. Metab. Biol. 1986, 36:98-105.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
14. Levy G. Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci. 1965, 54:959-967.
15. Lino Cardenas C.L., et al. Genetic polymorphisms of glycine N-acyltransferase (GLYAT) in a French Caucasian population. Xenobiotica 2010, 40:853-861.
16. Liska D.J. The detoxification enzyme systems. Altern. Med. Rev. 1998, 3:187-198.
17. Matsuo M., et al. Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2012, 420:901-906.
18. Mawal Y.R., Qureshi I.A. Purification to homogeneity of mitochondrial acyl CoA:glycine n-acyltransferase from human liver. Biochem. Biophys. Res. Commun. 1994, 205:1373-1379.
19. Mitchell G.A., Gauthier N., Lesimple A., Wang S.P., Mamer O., Qureshi I. Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol. Genet. Metab. 2008, 94:4-15.
20. Nandi D.L., Lucas S.V., Webster L.T. Benzoyl-coenzyme A:glycine N-acyltransferase and phenylacetyl-coenzyme A:glycine N-acyltransferase from bovine liver mitochondria. Purification and characterization. J. Biol. Chem. 1979, 254:7230-7237.
21. Nebert D., McKinnon R., Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol. 1996, 15:273-280.
22. Ogier D.B., Saudubray J.M. Branched-chain organic acidurias. Semin. Neonatol. 2002, 7:65-74.
23. Pettersen E.F., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
24. Sachdev D., Chirgwin J.M. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin. Protein Expr. Purif. 1998, 12:122-132.
25. Sakuma T. Alteration of urinary carnitine profile induced by benzoate administration. Arch. Dis. Child. 1991, 66:873-875.
26. Schachter D., Taggart J.V. Glycine N-acylase: purification and properties. J. Biol. Chem. 1954, 208:263-275.
27. Smith P.K., et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
28. Stadtler S.C., et al. Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA carboxylase. Biochem. Biophys. Res. Commun. 2005, 939-946.
29. Swinney R., Hsu S., Tomlinson G. Phase I and phase II enzyme polymorphisms and childhood cancer. J. Investig. Med. 2006, 54:303-320.
30. Tanaka K., Isselbacher K.J. The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia. J. Biol. Chem. 1967, 242:2966-2972.
31. Tanaka K., Budd M.A., Efron M.L., Isselbacher K.J. Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc. Natl. Acad. Sci. U. S. A. 1966, 56:236-242.
32. Temellini A., Mogavero S., Giulianotti P.C., Pietrabissa A., Mosca F., Pacifici G.M. Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 1993, 23:1427-1433.
33. Tremblay G., Quereshi I. The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen. Pharmacol. Ther. 1993, 60:63-90.
34. van der Westhuizen F.H., Pretorius P.J., Erasmus E. The utilization of alanine, glutamic acid, and serine as amino acid substrates for glycine N-acyltransferase. J. Biochem. Mol. Toxicol. 2000, 14:102-109.
35. Vetting M.W., et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 2005, 433:212-226.
36. Wallig M.A. Glucuronidation and susceptibility to chemical carcinogenesis. Toxicol. Sci. 2004, 1-2.
37. Waluk D.P., Schultz N., Hunt M.C. Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J. 2010, 24:2795-2803.
38. Waluk D.P., Sucharski F., Sipos L., Silberring J., Hunt M.C. Reversible lysine acetylation regulates the activity of human glycine n-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signalling molecules. J. Biol. Chem. 2012, 287(20):16158-16167. (May 11 2012).
39. Yamamoto A., Nonen S., Fukuda T., Yamazaki H., Azuma J. Genetic polymorphisms of glycine N-acyltransferase in Japanese individuals. Drug Metab. Pharmacokinet. 2009, 24:114-117.